M. Saruc Et Al. , "Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B," 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , vol.38, İstanbul, Turkey, pp.169, 2003
Saruc, M. Et Al. 2003. Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B. 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , (İstanbul, Turkey), 169.
Saruc, M., Ozden, N., Turkel, N., Hock, L., Ayhan, S., & Tuzcuoglu, I., (2003). Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B . 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (pp.169). İstanbul, Turkey
Saruc, Murat Et Al. "Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B," 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 2003
Saruc, Murat Et Al. "Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B." 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , İstanbul, Turkey, pp.169, 2003
Saruc, M. Et Al. (2003) . "Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B." 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , İstanbul, Turkey, p.169.
@conferencepaper{conferencepaper, author={Murat SARUC Et Al. }, title={Long term efficacy of interferon and thymosin combination in comparison to lamivudine plus interferon and interferon monotherapy in patients with HBeAg negative chronic hepatitis B}, congress name={38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver}, city={İstanbul}, country={Turkey}, year={2003}, pages={169} }